arsenic has been researched along with Rhabdoid Tumor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahlfeld, J; Bartelheim, K; Frühwald, MC; Handgretinger, R; Holsten, T; Hotfilder, M; Kerl, K; Kool, M; Meisterernst, M; Mertins, J; Moreno, N; Schleicher, S; Schüller, U | 1 |
1 other study(ies) available for arsenic and Rhabdoid Tumor
Article | Year |
---|---|
Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Proliferation; Computational Biology; Gene Expression Profiling; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Kruppel-Like Transcription Factors; Mice; Mice, SCID; Neoplasm Transplantation; Oxides; Prognosis; Rhabdoid Tumor; Signal Transduction; Transcription Factors; Zinc Finger Protein GLI1 | 2014 |